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MICROTUBULE PROTEIN
Identification in and Transport to Nerve Endings
INTRODUCTION
The protein subunit of microtubules, tubulin, is
present in the brain in large quantity (1-3).
Tubulin has a sedimentation velocity of 6S in the
120,000 dalton native dimeric form, binds colchi-
cine (2-4), and is precipitable by vinblastine
(5, 6, 7, 8) . The role of microtubules in brain is un-
defined. As in other cells, they have been linked
to morphogenesis and to stability of form . They
also have been implicated in axoplasmic transport
(8) . Most studies of microtubular function in
brain have relied on mitotic spindle inhibitors (19-
2 1) as a tool for interruption of the integrity of the
microtubule and the subsequent assay of the ef-
fect of this disruption. A serious difficulty in the
interpretation of such experiments is a lack of
knowledge of the transport and destination of
tubulin itself. Previous studies have suggested (17)
that tubulin is transported with the slow com-
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ABSTRACT
The subunit protein of microtubules, tubulin, has been demonstrated to be present in
isolated nerve endings by gel electrophoresis, amino acid composition, and peptide map-
ping. The tubulin constitutes approximately 28% of the soluble protein of the nerve endings.
The transport of tubulin to the nerve endings has been demonstrated and its relationship
to slow transport is discussed.
ponent of transport, but this is based on indirect
evidence. A second problem is that morphological
studies (28) reveal few, if any, microtubules at
nerve endings. Also, if tubulin is transported with
slow flow, certain evidence suggests that slow flow
may not enter the synaptic expansion itself (29).
To resolve these problems we have attempted to
apply the axoplasmic flow technique of Barondes
(11) in which flow is assessed by comparing the
levels of labeled protein in isolated synaptosomes
to levels of the same material in whole brain at
varied time intervals after the injection of labeled
precursor. The results demonstrate the transport
of tubulin to the nerve ending and its presence in
large quantity in the ending and lend support to
the conclusion that this transport is in the slow
component.
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Synaptosomal Isolation
CD 1 or BALB/c mice between the ages of 3 and 7
days were used for these experiments . Subcellular
fractionation and isolation of the synaptosomal frac-
tion were done by a slight modification of the pro-
cedure of Gray and Whittaker (10) as described
previously (11). The major modification involves the
washing of the crude mitochondrial fraction three
times with 0.32 M sucrose to ensure removal of ad-
sorbed soluble protein. The nerve ending (synapto-
somal) fraction was lysed with 5 ml of water at 0°C
and the lysed preparation was centrifuged at 100,000 g
for 1 hr to yield a soluble component of the nerve
ending fraction (NES) and a particulate component
(NEP). In the experiments in which radioactive
amino acid incorporation into brain protein was
studied, mice received a single intracerebral injec-
tion of 10 sCi of L-leucine 4,53H (4 mCi/mmole,
New England Nuclear Corp ., Boston, Mass.) in
10 µl of isotonic saline in the temporal region of the
brain 15 min, 90 min, or 24 hr before sacrifice . The
whole soluble fraction (WS) was prepared by taking
the supernatant from the crude mitochondrial
preparation above and centrifuging it at 100,000g
for 1 hr and utilizing the supernatant for further
study while discarding the pellet. The fraction pro-
vides an index of neuronal cell body levels of labeled
materials for comparison with the levels in isolated
synaptosomes. A major problem here is that the WS
contains not only neural but also glial cytoplasm and
quite possibly cytoplasm from nerve endings which
may have ruptured during initial homogenization .
The former problem is eased slightly by the fact that
the immature mouse brain is relatively poor in glial
cells.
Vinblastine Precipitation
The protein concentrations of the 100,000 g super-
natant from whole brain homogenate (WS) and from
the soluble component of the nerve ending fraction
(NES) were adjusted to 1-2 mg/ml, and MgC12,
sodium phosphate buffer (pH 7.0), and vinblastine
sulfate were added to final concentrations of 0 .01 M,
0.01 M, and 5 X 10-° M, respectively. The vinblastine
sulfate was obtained from Eli Lilly & Co., Indianapo-
lis, Ind. The mixture was incubated at 37 °C for % hr
(5) and the precipitate was collected by centrifuga-
tion at 35,000 g for 15 min . Control experiments
revealed 1007 sedimentation of colchicine binding
activity under these conditions, and polyacrylamide
gels of supernatant and pellet revealed all protein
which co-migrated with a tubulin standard to be
precipitated. The purity of the precipitates was
estimated at 90-95% by densitometric scans of gels
stained in amido-Schwarz. Similar estimates of
purity were obtained by fractionation and counting
of the gels after radioactive labeling of the protein .
Since the results presented in this paper are based
on liquid scintillation counting and protein deter-
mination on the entire precipitate, they will over-
estimate the actual amount of tubulin by 5-10% of
the experimental figures. Therefore, all determina-
tions of quantities of tubulin in the following sections
are diminished by 10% from their experimental
values to compensate for this error. Scans on such
precipitates are shown in Fig . 2 a.
Since higher purity was desired for peptide map-
ping and amino acid composition studies, the vin-
blastine precipitates were resolubilized by dialysis
against 0.01 M phosphate buffer, pH 7.0, and the
final solution was clarified by centrifugation at
6000 g for 20 min. The final supernatant was then
taken for study. The insoluble pellet amounted to
10-20% of the total protein of the original precipitate
and contained up to 40% tubulin as determined by
gel electrophoresis. The supernatant was 98-997
pure tubulin as determined by densitometry and
counting of labeled protein. Typical gels of such a
preparation are shown in Fig . 2 b.
Polyacrylamide Gel Electrophoresis
Protein samples were reduced in ß-mercaptoethanol
and alkylated with iodoacetamide in the presence of
8 M urea (12), except in the case of samples to be run
on neutral sodium dodecyl sulfate (SDS) gels in
which case the urea was omitted. Three types of gel
systems were used : (a) the neutral pH gel system
incorporating 0.1 % sodium dodecyl sulfate (SDS) in
which the proteins migrate according to molecular
weight (13). The bands in this system tend to be
quite broad; (b) the discontinuous gel system of
Davis (14) modified by the inclusion of 8 M urea in
the gel ; (c) the Davis system as modified by Albert
et al. (15) with the inclusion of both 8 M urea and
0.1 % SDS in the gel and 0.1 % SDS in the buffer ;
separation in this system is by molecular weight over
the range of 30,000-135,000 daltons . The acrylamide
concentration in each case was 7 .5%. Gels were
fixed overnight in a 50/50 mixture of 7% acetic acid
in water and 7% acetic acid in methanol . Staining
was done for 8 hr in amido-Schwarz, followed by
electrophoretic destaining in a transverse destaining
apparatus. Amido-Schwarz was chosen for staining
because it represented a reasonable compromise
between sensitivity and quantitation . The more sensi-
tive Coomasie blue is nonlinear for tubulin, while
amido-Schwarz gave better agreement with actual
protein concentrations. Samples of WS and NES
stained in amido-Schwarz and in the more quantita-
tive fast green (30) differed by only a small percent-
age for any single peak .
Gels used for radioactive experiments were all run
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1.39with identical amounts of protein . The protein pro-
files within the NES and WS fractions remained
constant with time as determined by densitometry .
Differences exist, of course, between the profiles from
NES and WS. Proteins were labeled with tritiated
leucine, and a 14C-labeled tubulin standard was used
for calibration. Gel slices were solubilized for counting
in NCS reagent and counted in Bray's solution (31).
Peptide Mapping
Protein samples were reduced and alkylated (12)
and aliquots were checked for purity by gel electro-
phoresis. The samples were then dialyzed for 24 hr
against 0.1 M ammonium carbonate at pH 8.5
followed by digestion with trypsin (DCC-treated,
Calbiochem, Los Angeles, Calif.) at an enzyme-to-
protein ratio of 1 :50 for 14 hr at 37°C. Tubulin
samples used were in the range of 300-400 µg for
each map. Thin-layer peptide maps were prepared
by the method of Ritschard (16) . The tryptic peptides
were spotted on 20-cm square silica gel G plates
(Analtech, Inc., Wilmington, Del.) and chromato-
graphed in an ascending propanol-acetic acid-water
solvent system in a volume ratio of 7 :1 :2. The plates
were dried in an oven at 100 °C for 10 min and then
electrophoresed in a flat-bed apparatus with paper
wicks at 10,000 v for 90 min. The buffer for electro-
140
	
THE JOURNAL OF CELL BIOLOGY . VOLUME 51, 1971
phoresis was pyridine-acetic acid-water in volume
ratios of 1 :10:489. The plates were dried at 110°C,
and sprayed with ninhydrin in a trimethylpyridine-
acetic acid buffer. The color was developed by heating
the plates at 80°C for a few minutes.
Protein Determinations
Protein was determined colorimetrically by the
method of Lowry et al. (32). The analysis was stand-
ardized using crystalline bovine serum albumin.
Since the indole rings in vinblastine can interfere
with the Lowry determination and give falsely high
results, all samples were precipitated with 10% tri-
chloroacetic acid (TCA) and washed twice in 107
TCA before analysis. No differences are seen between
equal samples of tubulin, one of which was vinblastine
precipitated and one not, after this treatment .
Amino Acid Analysis
Samples were hydrolyzed in 6 N HCI in sealed
evacuated tubes at 110°C for 24 and 48 hr . The
protein concentrations were made equal in all
samples in order to control for possible side reactions
between the amino acid and sugar moieties. Samples
were analysed using a 4 hr, two-column methodology
on a Jeolco 5AH analyser (Jeolco U . S. A. Inc.,
Medford, Mass.) .
FIGURE 1 A typical field of isolated nerve endings prepared from 3-7 day old mice. Note presence of
some neurotubules and neurofilaments (arrows). X 10,000.MIGRATION IN CM .
FIGURE 2 Fig. 2 a, Polyacrylamide gel electrophoresis
(8 mI urea gels ; Materials and Methods, gel system b)
of tubulin prepared from NES fraction (solid line) and
WS fraction (dotted line) . Gels were stained with
amido-Schwarz and scanned on a Joyce-Loebl Chromo-
scan densitometer (Joyce, Loebl & Co., Inc., Burling-
ton, Mass.). Migration is from left to right with an-
ode at right. Fig. 2 b, photograph of polyacrylamide
gels (8 mI urea-SDS ; Materials and Methods, gel sys-
tem c) of tubulins prepared from NES fraction (a) and
from WS fraction (b). The two bands in each are equal
in concentration and may represent the monomers of
the tubulin dimer or two species of tubulin .
FEIT, DUTTON, BARONDES, AND SHELANSKI Microtubule Protein
	
141TABLE I
Amino Acid Compositions of Tubulin Purified from
NES and WS Fractions
All values are expressed in moles per cent . Values
for threonine and serine were corrected for de-
struction by extrapolation to zero time from 24 and
48 hr determinations .
Electron Microscopy
Pellets were fixed in 2 .5% glutaraldehyde in 0.1 M
phosphate buffer at pH 7 .4 for 1 hr at room tempera-
ture and postfixed with 1 % buffer osmium tetroxide
for 1 hr. Dehydration was carried out in graded
alcohols from 70% to absolute, followed by em-
bedding in Epon 812 . Sections were cut on a Reichart
ultramicrotome (Reichart, Inc., Austria) and exam-
ined with a Siemens IA electron microscope.
RESULTS
Identification of Microtubule Protein
in the Soluble Components of the Nerve
Ending Fraction
Isolated synaptosomes were obtained from the
brains of immature mice at a high level of purity
(Fig. 1). With the vinblastine precipitation pro-
cedure, 28% of the total protein of the NES frac-
tion and 15% of the total protein of the WS frac-
tion were recovered. Proteins from NES and WS
purified by the vinblastine procedure co-migrated
with microtubule protein purified from porcine
brain by the method of Weisenberg et al . (3) on all
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three gel systems which were used . Co-migration
was established by examining the electrophoresis
pattern of appropriate mixtures as well as with
parallel gels. In the 8 M urea system, all samples
ran as single discrete bands. In the 8 M urea-SDS
system, all the samples ran as a well-resolved
double band (Fig. 2 b) with apparent molecular
weights of 56,000 and 53,000, respectively, on a
calibrated gel . It is not clear whether such small
differences in molecular weight are significant in
this system. The splitting may represent resolution
of two nonidentical tubulin monomers or the
presence of two tubulins in brain (27). This
splitting is obtained on single bands eluted from
8 M urea gels and rerun on this system. Each band
seen can be eluted and rerun on the same system
giving a single band .
Amino acid compositions of the proteins from
WS and NES purified by the vinblastine procedure
were virtually indistinguishable from each other
(Table I) . Comparative peptide maps of this
material were also strikingly similar (Fig . 3). Of
the 51 peptides detected, 43 appear to be the same
in the two preparations.
The combination of results of the electro-
phoretic, amino acid, and peptide mapping studies
established that the proteins purified by the vin-
blastine procedures from both NES and WS are
similar and suggest that both of them are tubulin .
The possibility that the tubulin found in the NES
was due to contamination of the nerve ending
fraction by adsorbed tubulin from WS was evalu-
ated in the previous study (9) . It was shown that,
upon mixing radioactively labeled protein from
WS with unlabeled homogenates and then iso-
lating NES, less than 4% of the protein of NES
represented contamination by WS. Even if all the
WS contamination was tubulin, this would ac-
count for less than 25% of the tubulin recovered
from NES. Homogenization of brain in the pres-
ence of labeled WS also revealed less than 4%
contamination of NES by WS .
Transport of Tubulin to Nerve Endings
The specific activity of tubulin in NES and WS
at a number of times after intracerebral injection
of radioactive leucine was determined. The protein
of WS was maximally labeled within 90 min after
intracerebral injection of radioactive leucine, and
the specific activity of this protein declined there-
after (Fig. 4 a) . In contrast, the protein of NES was
only slightly labeled at early time points, and the
WS Tubulin
	
NES Tubulin
Lysine 4.7 4 .7
Histidine 2 .4 2 .4
Arginine 4.3 4.3
Aspartic acid 10 .8 10.4
Thréonine 6.6 6 .6
Serine 6 .7 6 .7
Glutamic acid 13 .7 13 .7
Proline 4.5 4 .7
Glycine 7 .9 7 .8
Alanine 8 .1 8 .4
;2-Cystine trace trace
Valine 7 .0 6 .7
Methionine 2 .8 2 .7
Isoleucine 4 .2 4 .2
Leucine 9.3 9 .3
Tyrosine 3 .4 3 .1
Phenylalanine 4.4 4 .1
Tryptophan not determined0
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FIGURE 3 Tryptic peptides of tubulin prepared from NES (Fig . 3 a) and from WS (Fig. 3 b) on silica
gel G thin-layer plates as described in the text . Regions Y and Z are groups of peptides which are re-
solved by less than one spot diameter . Peptides common to both NES and WS tubulin are shown as
open circles. Peptides a-e were found exclusively in WS tubulin ; peptides g and f exclusively in NES
tubulin. Figures are tracings based on duplicate determinations .
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143specific activity of this protein rose considerably in
the interval between 90 min and 24 hr (Fig . 4 b) .
The delayed appearance of labeled protein in NES
is believed to be due to transport of this protein
from its site of synthesis, presumably in the nerve
cell body, to the nerve terminal (11). The present
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SOLUBLE OF
WHOLE BRAIN
experiments suggest that a major component of
the radioactive soluble protein transferred to the
nerve terminal is tubulin . To evaluate this further,
protein from NES and WS was purified by the
vinblastine procedure at a number of times after
intercerebral injection of radioactive leucine.
FRACTION
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FIGURE 4 Polyacrylamide gel electrophoresis (Materials and Methods, system a) of total proteins of
WS and NES fractions labeled with tritiated leucine. Groups of six 5-day-old mice were each injected
intracerebrally with 10 ACi of L-leucine, 4,5- 3H and sacrificed 15 or 90 min or 24 hr later. WS (a) and
NES (b) were reduced, alkylated, and 0.25 mg protein was electrophoresed along with 50 µg of tubulin-
14C. All the counts were multiplied by four so that the data are expressed as if 1 mg of protein was applied
to acid gel. The tubulin standard is shown beneath each trace as a dotted line . Dashed lines represent
density traces on parallel gels. Fast green stain.
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Whereas the specific activity of vinblastine-puri-
fied protein from WS declined markedly between
90 min after intracerebral injection and 7 days,
the specific activity of this protein in NES rose
strikingly (Table II) and the ratio of the specific
activity of the vinblastine-purified protein in NES
over that from WS continued to rise over the 1 wk
period in which the study was performed. This
indicates the transport of tubulin from a peri-
karyal site of synthesis to the nerve terminal, and
makes unlikely the possibility that NES tubulin is
the result of WS contamination .
Other possibilities to explain these results could
include synthesis of tubulin at nerve endings .
However, the striking lag between administration
of radioactive leucine and appearance of labeled
tubulin in NES, coupled with the disappearance
of free radioactive leucine within 1 hr of its intra-
cerebral injection (11), argue strongly against this .
DISCUSSION
In a previous report we have shown that nerve
ending fractions bind colchicine and that a
significant proportion of NES protein is precipi-
table by vinblastine and is composed of subunits
which are monomeric after reduction and alkyla-
tion with a molecular weight of approximately
60,000 daltons (9) . Although the whole nerve
ending fraction bound colchicine, NES had no
detectable colchicine binding activity (9). We at-
tributed the loss of colchicine binding activity to
the prolonged isolation procedure in the absence
of magnesium and the marked dilution of NES
during water lysis of the nerve ending fraction ;
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145TABLE II
Specific Activity of Tubulin from NES and WS
Fractions, Purified by Vinblastine
Precipitation
cpm mg protein
NES and WS were isolated at the indicated times
after intracerebral injection of groups of eight 5-
day-old mice with 10 zCi of tritiated leucine into
each mouse ; and tubulin was purified by vin-
blastine precipitation, solubilized in buffer, and
reprecipitated with cold 5% trichloroacetic acid.
Radioactivity and protein were then determined .
but it remained possible that the vinblastine-
precipitable protein of NES was not tubulin . The
present experiments demonstrate clearly that the
electrophoretic migration, amino acid composition,
and peptide map of the vinblastine-purified pro-
tein from NES is similar to that of tubulin prepared
from whole mouse brain. It, therefore, seems quite
certain that tubulin is a prominent constituent of
the nerve ending fraction .
The present experiments are in accord with the
observation that tubulin is slowly transported from
the nerve cell body into the nerve ending . Previous
studies on axoplasmic transport have demonstrated
that intraocularly injected colchicine1H is trans-
ported along the optic nerve, presumably bound
to tubulin, with a velocity in the range of the slow
component of axoplasmic flow (17) . Other studies
have shown that a substantial portion of the radio-
actively labeled protein transported in nerve with
the slow component of axoplasmic flow is similar
to tubulin (18, 19) . Although it is clear that at
least the great majority of the tubulin of NES is
transported there slowly, some labeled tubulin is
already detected in NES within 15 min after in-
jection of radioactive leucine. We have previously
suggested that some tubulin of NES is transported
rapidly to the nerve ending (24), and evidence
suggesting rapid transport of some tubulin in the
axon has been presented by others (19). The
possibility that a component of tubulin is trans-
ported rapidly in the axon, and the state of molec-
ular organization of the tubulin which is trans-
ported, require further study. Likewise, the
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relationship of transport of tubulin in the axon to
the effects of vinblastine and colchicine on slow
and rapid axoplasmic transport (20-23) remains
to be determined .
The small differences in the peptide maps of
tubulin from NES and WS may be due to con-
tamination due to variation in purification, but
they may be due to small differences in the tubulin
itself. It has been demonstrated (25) that proteins
may be modified by the addition of glucosamine
and other sugars at nerve endings . Other possible
changes which would change peptide mapping
characteristics include phosphorylation (26), de-
phosphorylation, and covalent linkage of nucleo-
tide. Recent unpublished results from this labora-
FIGURE 5 Polyacrylamide gel electrophoresis (8 M
urea-SDS, Materials and Methods, system c) of tubu-
lin from WS (a), the insoluble proteins remaining
after 2X water lysis and high speed centrifugation of
the nerve ending fraction (b), and a mixture of the
two samples (c).
Time after
injection WS NES NES/WS
90 min 175,000 17,000 0 .10
1 day 114,000 38,000 0 .33
3 days 54,000 49,000 0 .91
7 days 27,000 21,000 0 .78tory show the presence of hexosamines and the
absence of sialic acid in purified tubulin prepara-
tions and the incorporation of radioactivity into
tubulin at nerve endings after intracerebral in-
jection of glucosamine- 1¢C. Modifications of this
sort might be preliminary to the incorporation of
tubulin into membranes, to secretion from the
nerve ending, or simply preparatory to degrada-
tion.
In previous studies we have demonstrated that
the particulate component of isolated nerve
ending fractions binds colchicine (9). Electro-
phoretic study of the proteins of this fraction on
SDS-urea gels reveals a large number of bands
including two prominent bands which migrate
with a velocity identical to that of purified brain
tubulin (Fig. 5) . This observation strengthens the
hypothesis that tubulin may be associated in some
manner with membranes at the nerve ending .
However, similarity in amino acid compositions
and peptide maps must be demonstrated before
the presence of tubulin in the particulate fraction
can be firmly established .
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